Navigation Links
Pandemic vaccination did not increase risk of fetal death
Date:1/17/2013

With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets & therapeutics provides new opportunities for the prevention and treatment of several major disease systems. The 4th Cancer Targets & Therapeutics Conference, taking place on February 25-26, 2013 in Las Vegas, NV will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact. Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer.

Attendees will learn about:

  • Important progress in key aspects of antibody, vaccine, and cell-based therapies being developed and evaluated in clinical trials for the immunotherapy of cancer

  • How cellular pathways of protein processing and pivotal cell-death pathways are being targeted by new Therapies New therapeutic targets in epigenetic and newly described metabolic pathways that serve as new pathways for drug discovery

  • Advances in targeting angiogenesis

  • Important new animal models for target validation

  • New approaches to drug-conjugates and to dose evaluation for effective therapy

Preliminary Sessions for 2013 Agenda:

  • Novel Kinase Inhibitors & Beyond the Kinome

  • Functional Genomics & Future Cancer targets

  • Novel Antibody-based Modalities

  • Progress in Cancer Immunotherapy

  • Cancer Stem Cells, Metabolism, Cancer Epigenetics

  • Novel Advances & Technologies in Oncology


'/>"/>

Contact: Press Officer
47-210-78300
Norwegian Institute of Public Health
Source:Eurekalert

0

GOOD

Page: 1

Related biology news :

1. Improving equine health: Research studies vaccinations to protect newborn foals
2. The effect of treatment with antibiotics and vaccination against Q fever in sheep
3. Teens susceptible to hepatitis B infection despite vaccination as infants
4. Increase in Arctic shipping poses risk to marine mammals
5. Columbia Engineering and Penn researchers increase speed of single-molecule measurements
6. Fertilizer use responsible for increase in nitrous oxide in atmosphere
7. NIST/UMass study finds evidence nanoparticles may increase plant DNA damage
8. Study finds soda consumption increases overall stroke risk
9. Scientists have discovered genes that increase the risk of osteoporosis and fractures
10. Family history of liver cancer increases risk of developing the disease
11. Research shows how PCBs promote dendrite growth, may increase autism risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... The iCargo project (Intelligent Cargo in Efficient and Sustainable ... thanks to an improvement in the efficiency of intermodal ... assist decision making. It comprises 29 European organisations with ... management. It has a budget totalling 17,000,000 and a ... is working to specify and develop the semantic components ...
(Date:5/17/2013)... LEMONT, Ill. An international team ... internal structure and cell movement inside a living frog ... showcases a new method to advance biological research and ... at Northwestern University and the Karlsruher Institut fr Technologie ... at the U.S. Department of Energy,s Argonne National Laboratory, ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) Program ... Society for Developmental Biology (SDB) 72nd Annual Meeting ... awards are meant to promote the entry of ... the mainstream of the basic science community and ... the SDB 2013 Annual Meeting. , Awards are ...
Breaking Biology News(10 mins):New logistics services that will cut energy consumption and CO2 emissions 2New X-ray method shows how frog embryos could help thwart disease 2
... scientists, mathematicians, and biologists from around the world have ... genetic ancestry of thousands of individuals in minutes, without ... will be published in the September 2007 edition of ... of its kind that require prior knowledge of an ...
... RESTON, Va. -- Based on the results of a ... basic molecular imaging/nuclear medicine research should be restored to ... largest society for molecular imaging and nuclear medicine professionals. ... National Institutes of Health, the 13-month, $700,000 report was ...
... Veterinary Medicine have demonstrated the potential of a new ... method employs a harmless gene therapy virus that transfers ... then passed naturally on to offspring. Ina Dobrinski, ... Transgenesis and Germ Cell Research at Penn Vet, and ...
Cached Biology News:Computer program traces ancestry using anonymous DNA samples 2SNM applauds NAS study showing need to restore federal nuclear medicine research funding 2SNM applauds NAS study showing need to restore federal nuclear medicine research funding 3Penn Veterinary Medicine report new strategy to create genetically-modified animals 2
(Date:5/16/2013)... Auckland, New Zealand (PRWEB) May 16, 2013 ... Zealand, was invited to speak to doctors in China about ... across Australia and NZ, this was her first trip to ... , Dr. Hart visited Guangzhou and Fuzhou, home to 12 ... treatments in China is very high at this point in ...
(Date:5/16/2013)... Kitware , a leading ... new Phase II SBIR funding from the U.S. ... an open-source, high performance computing (HPC) simulation and ... researchers to select only the toolkits and applications ... or analysis tasks. , Manufacturers increasingly rely ...
(Date:5/16/2013)... , May 16, 2013 Scientists at the ... Beijing , and the California ... demonstrated a novel therapy for reversing memory decline in ... they find significant cognitive improvement in advanced stage AD ... mechanism for reversing cognitive decline for advanced stage AD ...
(Date:5/16/2013)... YORK , May 16, 2013 ... new market research report is available ... Competitor Analysis: Therapeutic ... http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical ...   The new ...
Breaking Biology Technology:Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8
... 11, 2011 /PRNewswire-Asia/ -- Chinmax Medical Systems Inc., a ... regarding the progress of its lawsuit against Inverness Medical ... According to the Complaint, Inverness Medical Beijing ... the same to Chinmax customers during the period when ...
... SAN DIEGO, April 11, 2011 MabVax Therapeutics, Inc., ... the development of vaccine and antibody based therapies to ... announces that it has received the Phase 2 portion ... the National Cancer Institute (NCI) under the agency,s Streamlined ...
... VIGILAIR Systems, an industry leader in Ultraviolet Germicidal ... and first of its kind hospital study that demonstrated ... with the application of VIGILAIR® air cleaning technology in ... published article , Effect of enhanced ultraviolet germicidal irradiation ...
Cached Biology Technology:Beijing Chaoyang District Court Grants Investigation Letters Against Inverness Medical Beijing, A Subsidiary of Alere Inc. 2MabVax Therapeutics Receives $1.8 Million in a Phase 2 Small Business Innovation Research Program Award From the National Cancer Institute 2MabVax Therapeutics Receives $1.8 Million in a Phase 2 Small Business Innovation Research Program Award From the National Cancer Institute 3Newly Published Study Shows Dramatic Reduction in Hospital Acquired Infections 2
Purified anti-human CD182 (CXCR2)...
Polyclonal Antibody to AGAP1 / Centaurin, gamma 2...
Mouse monoclonal [b/e4 (9.20)] to Cytochrome P450 2B1 + 2B2 ( Abpromise for all tested applications)....
Goat polyclonal to MLH3 Immunogen: Synthetic peptide: RQSLQQSMPPCEPP (Human) from C Terminus of the protein sequence according to NP_055196....
Biology Products: